Journals / Clinical and Experimental Health Sciences / 2015 / Cilt: 5 - Sayı: 1

Role of the cholinergic anti-inflammatory pathway in endotoxemia-induced multi-organ damage in the rat

Sıçanda endotoksemiye bağlı çoklu organ hasarında kolinerjik anti-inflamatuvar yolun rolü

Pages
21–30
Publication Date
2015-05-03
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Beneficial effects of nicotine seemed to persist in the presence of other therapies.Conclusions: Nicotine in sepsis protects the tissues partially via activation of the cholinergic anti-inflammatory pathway independently of the iNOS and COX-2.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To investigate the role of the cholinergic anti-inflammatory pathway and interaction of inducible nitric oxide (iNOS) and cycloxygenase (COX)-2 in organ dysfunction in rat sepsis.
📊
Key Findings & Data:Methods: Lipopolysaccharide (LPS) (10 mg/kg; intraperitoneally) was given to Sprague-Dawley rats to induce sepsis.
💡
Conclusion & Impact:Beneficial effects of nicotine seemed to persist in the presence of other therapies.Conclusions: Nicotine in sepsis protects the tissues partially via activation of the cholinergic anti-inflammatory pathway independently of the iNOS and COX-2.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Sepsis · sıçan · kolinerjik anti-inflamatuvar yol

Abstract

Objective: To investigate the role of the cholinergic anti-inflammatory pathway and interaction of inducible nitric oxide (iNOS) and cycloxygenase (COX)-2 in organ dysfunction in rat sepsis. Methods: Lipopolysaccharide (LPS) (10 mg/kg; intraperitoneally) was given to Sprague-Dawley rats to induce sepsis. Groups were treated with nicotine alone or with nicotinic receptor antagonist mecamylamine (3 mg/kg; subcutaneously), selective iNOS inhibitor aminoguanidine (8 mg/kg; intraperitoneally) or selective COX-2 inhibitor nimesulide (8 mg/kg; intraperitoneally). Six hours after LPS, liver, kidney and lung samples were obtained for malondialdehyde (MDA), glutathione (GSH), myeloperoxidase (MPO), chemiluminescence assays and microscopic evaluation and blood was obtained for alanine transaminase (ALT), aspartate aminotransferase (AST) and blood urea nitrogen (BUN) assays. Results: Sepsis increased ALT (p<0.05), AST (p<0.01) and BUN (p<0.001), tissue MDA (p<0.01 for liver and p<0.05, for kidney and lung), tissue MPO (p<0.01, for liver; p<0.05, for kidney; p<0.001, for lung) and chemiluminescence (luminol p<0.001, for all tissues; lucigenin p<0.001 for liver and p<0.01 for kidney and lung) while decreasing GSH (p<0.01, for liver and kidney) compared to control. Nicotine prevented the increase in ALT, AST and BUN (p<0.05, for each), increase in liver and renal MDA (p<0.05, for each), consumption of GSH (p<0.01, for liver and kidney), injury score (p<0.05, for liver and kidney) and increased MPO (p<0.05, for liver and p<0.01, for kidney and lung). Beneficial effects of nicotine seemed to persist in the presence of other therapies.Conclusions: Nicotine in sepsis protects the tissues partially via activation of the cholinergic anti-inflammatory pathway independently of the iNOS and COX-2.

Özet

Amaç: Sıçanda sepsise bağlı çoklu organ hasarında kolinerjik anti-inflamatuvar yolun rolünü araştırmak ve patojenezde indüklenebilir nitrik oksit sentaz (iNOS) ve siklooksijenaz (COX)-2 enzimlerinin etkileşimini incelemektir.Yöntemler: Sprague-Dawley sıçanlara lipopolisakkarid (LPS) (10 mg/kg; intraperitoneal) uygulanarak sepsis oluşturuldu. Tedavi gruplarına, LPS öncesi 3 gün süreyle nikotin (0.1 mg/kg; intraperitoneal) tek başına veya nikotinik reseptör antagonisti mekamilamin (3 mg/kg; subkutan), selektif iNOS inhibitörü aminoguanidin (8 mg/kg; intraperitoneal) veya selektif COX-2 inhibitörü nimesulid (8 mg/kg; intraperitoneal) ile birlikte uygulandı. LPS’den 6 saat sonra dekapite edilen sıçanların karaciğer, böbrek ve akciğer örneklerinde malondialdehid (MDA), glutatyon (GSH), myeloperoksidaz (MPO) aktivitesi, kemiluminisans ölçümleri ve hasar skorlaması yapıldı. Kanda alanin transaminaz (ALT), aspartat aminotransferaz (AST) ve üre azotu (BUN) ölçüldü. Bulgular: Sepsis kanda ALT (p<0.05), AST (p<0.01) ve BUN (p<0.001) düzeylerinde artışa, karaciğer, böbrek ve akciğerde MDA’da yükselmeye (sırası ile, p<0.01, p<0.05 ve p<0.05), MPO’da artışa (sırası ile, p<0.01, p<0.05 ve p<0.001), GSH’da azalmaya (karaciğer için p<0.01, böbrek için p<0.01) ve kemiluminisansta artışa (luminol her üç doku için p<0.001; lusigenin karaciğer için p<0.001, böbrek ve akciğer için p<0.01) neden oldu. Nikotin ALT, AST ve BUN düzeylerindeki yükselmeyi (her üç parametre için p<0.05), karaciğer ve böbrekte MDA artışını (sırası ile, p<0.05 ve p<0.05), GSH’daki azalmayı (sırası ile, p<0.01 ve p<0.01), doku hasarını (sırası ile, p<0.05 ve p<0.05) ve MPO artışını (karaciğer için p<0.05, böbrek için p<0.01 ve akciğer için p<0.01) engelledi. Nikotinin yararlı etkileri diğer tedaviler varlığında devam etme eğilimi gösterdi. Sonuç: Nikotin tedavisi sepsise bağlı karaciğer, böbrek ve akciğer hasarını olasılıkla iNOS ve COX-2 enzim sistemlerinden bağımsız mekanizmalarla korumaktadır.

🔖

Cite This Article

Kolgazi, M., Özgür, F., BEYAZOĞLU, Ö., Kocagöz, A., Çelik, M., ELMAS, M. A., Yüksel, M., Ercan, F., Alican, İ. (2015). Role of the cholinergic anti-inflammatory pathway in endotoxemia-induced multi-organ damage in the rat. Clinical and Experimental Health Sciences, Cilt: 5 - Sayı: 1, 21–30. https://ajindex.com/articles/481751

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003; 348: 138-150.
  2. Klijn E, Den Uil CA, Bakker J, Ince C. The heterogeneity of the microcirculation in critical illness. Clin Chest Med. 2008; 29: 643–654. Cauwels A. Nitric oxide in shock. Kidney Int. 2007; 72: 557–565.
  3. Bernik TR, Friedman SG, Ochani M, DiRaimo R, Susarla S, Czura CJ, Tracey KJ. Cholinergic anti-inflammatory pathway inhibition of tumor necrosis factor during ischemia reperfusion. J Vasc Surg. 2002; 36(6): 1231-1236.
  4. Guarini S, Altavilla D, Cainazzo MM, Giuliani D, Bigiani A, Marini H, Squadrito G, Minutoli L, Bertolini A, Marini R, Adamo EB, Venuti FS, Squadrito F. Efferent vagal fiber stimulation blunts nuclear factor- kappa B activation and protects against hypovolemic hemorrhagic shock. Circulation. 2003; 107: 1189-1194. van Westerloo DJ, Giebelen IA, Florquin S, Daalhuisen J, Bruno MJ, de Vos AF, Tracey KJ, van der Poll T. The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis. J Infect Dis. 2005; 191(12): 2138-2148.
  5. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Wang H, Yang H, Ulloa L, Al-Abed Y, Czura CJ, Tracey KJ. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature. 2003; 421: 384-388.
  6. Su X, Lee JW, Matthay ZA, Mednick G, Uchida T, Fang X, Gupta N, Matthay MA. Activation of the alpha7nAChR reduces acid-induced acute lung injury in mice and rats. Am J Respir Cell Mol Biol. 2007; 37(2): 186-192.
  7. Bencherif M, Lippiello PM, Lucas R, Marrero MB. Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases. Cell Mol Life Sci. 2011; 68(6): 931-949.
  8. Li J, Mathieu SL, Harris R, Ji J, Anderson DJ, Malysz J, Bunnelle WH, Waring JF, Marsh KC, Murtaza A, Olson LM, Gopalakrishnan M. Role of α7 nicotinic acetylcholine receptors in regulating tumor necrosis factor-α (TNF-α) as revealed by subtype selective agonists. J Neuroimmunol. 2011; 239(1-2): 37-43. de Jonge WJ1, van der Zanden EP, The FO, Bijlsma MF, van Westerloo DJ, Bennink RJ, Berthoud HR, Uematsu S, Akira S, van den Wijngaard RM, Boeckxstaens GE. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol. 2005; 6: 844-851.
  9. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev. 1991; 43: 109- 142. Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Pu